SCHEMBL7078085

SCHEMBL7078085

Cc1nn(C)c2nc(OCCC3CCCCN3)c(N(C=O)C(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.42
CCR5 P51681 1/20 0.42
UBE2M P61081 3/20 0.35
DCUN1D1 Q96GG9 3/20 0.35
ABL1 P00519 1/20 0.35
LCK P06239 1/20 0.35
CSF1R P07333 1/20 0.35
LYN P07948 1/20 0.35
KIT P10721 1/20 0.35
SRC P12931 1/20 0.35
FLT1 P17948 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
BLK P51451 1/20 0.35
MCHR1 Q99705 10/20 0.34
KCNN4 O15554 1/20 0.34
RAF1 P04049 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5961508 0.99 CCR2 (0.42) CCR2CCR5UBE2MDCUN1D1ABL1
SCHEMBL7078116 0.98 CCR2 (0.43) CCR2CCR5UBE2MDCUN1D1ABL1
Hydrochloric Acid SCHEMBL5961462 0.97 CCR2 (0.42) CCR2CCR5UBE2MDCUN1D1ABL1
SCHEMBL5961516 0.84 CCR2 (0.48) CCR2CCR5UBE2MDCUN1D1ABL1
Hydrochloric Acid SCHEMBL5961442 0.84 CCR2 (0.48) CCR2CCR5UBE2MDCUN1D1ABL1
SCHEMBL5961583 0.84 CCR2 (0.48) CCR2CCR5UBE2MDCUN1D1ABL1
SCHEMBL5961428 0.83 CCR2 (0.47) CCR2CCR5UBE2MDCUN1D1ABL1
Hydrochloric Acid SCHEMBL5961505 0.83 CCR2 (0.47) CCR2CCR5UBE2MDCUN1D1ABL1
Hydrochloric Acid SCHEMBL5961466 0.83 CCR2 (0.46) CCR2CCR5UBE2MDCUN1D1ABL1
SCHEMBL5961496 0.81 CCR2 (0.48) CCR2CCR5UBE2MDCUN1D1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670364-B2 For example (1,3-dimethylpyrazolo(5,4-b)pyridin-5-yl)-N-(((4-fluorophenyl) amino)carbonyl)-carboxamide; useful in prevention or treatment of chronic or acute inflammatory or autoimmune diseases TELIK, INC. 2003-12-30 US claimed
EP-1358188-A2 ANTAGONISTS OF MCP-1 FUNCTION AND METHODS OF USE THEREOF TELIK, INC. (US) 2003-11-05 EP claimed
US-20030096705-A1 Antagonists of MCP-1 function and methods of use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2003-05-22 US claimed
WO-2002060900-A2 ANTAGONISTS OF MCP-1 FUNCTION AND METHODS OF USE THEREOF TELIK, INC. (US) 2002-08-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096705-A1 Antagonists of MCP-1 function and methods of use thereof CCR2, CCR1, CCL2 CCR2 1/4885CCR5 4/4885UBE2M 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.